Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer: A Review.

Prostate cancer is the second leading cause of cancer deaths in US men. The course of prostate cancer is highly variable, and timely and accurate detection of clinically significant cancer is critical in positively affecting outcomes.

Molecular imaging methods and magnetic resonance imaging (MRI) are the most promising new developments for prostate tumor visualization. While the benefits of MRI are many, positron emission tomography (PET) radiotracers are still available only as research tools.

The current research-based evidence on PET imaging has demonstrated encouraging potential in the initial diagnosis and detection of recurrence and metastases of prostate cancer.

JAMA oncology. 2017 Jan 12 [Epub ahead of print]

Maria L Lindenberg, Baris Turkbey, Esther Mena, Peter L Choyke

Molecular Imaging Program, National Cancer Institute, National Institute of Health (NIH), Bethesda, Maryland.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe